Supports investigator-initiated resources for high-priority projects or the broader allergy and infectious diseases research community when other NIAID support is unsuitable; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: January 25, 2027 (Applications) | May 25, 2027 (Applications) | September 25, 2027 (Applications) | January 25, 2028 (Applications) | May 25, 2028 (Applications) | September 25, 2028 (Applications) | January 25, 2029 (Applications) | May 25, 2029 (Final applications)
Funding Amounts: No budget limit (actual project needs must justify requests), for up to 5 years; no cost sharing required
Summary: Supports investigator-initiated, non-hypothesis-driven resources serving high-priority infectious disease, immunology, allergy, and related biomedical research.
Key Information: Clinical trials and foreign subawards/subcontracts are not allowed.
The National Institute of Allergy and Infectious Diseases (NIAID) supports investigator-initiated Resource-Related Research Projects through the R24 mechanism. Projects develop data, materials, tools, or services that significantly benefit currently funded, high-priority research needing coordination and support, or establish new resources for the broader NIAID scientific community. This mechanism is intended for infrequent use when other NIAID support mechanisms are inappropriate.
Resources should advance timely, high-quality, cost-efficient research within NIAID’s mission: microbial biology, pathogenesis, and host responses, including HIV; normal immune function and immune dysfunction; and vaccines, therapeutics, and diagnostics for infectious, immune-mediated, and allergic diseases. Resources should be available to qualified investigators, quality-controlled, replenishable, and nonduplicative of commercial or other existing resources.